Europe accelerates next-generation flu vaccines with €225m innovation procurement push

EUROPEAN BIOTECHNOLOGY MAGAZINE - A group of vaccine developers, biotech firms and public health institutes, including Bavarian Nordic and Sanofi, has secured framework contracts under a €225 million EU initiative to accelerate the development of next-generation influenza vaccines. Read more

Hadja Lahbib, European Commissioner for Equality and European Commissioner for Preparedness and Crisis Management. Source: EC - Audiovisual Service. Photographer: Aurore Martignoni